These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32987729)

  • 1. Characterization of Hematopoiesis in Sickle Cell Disease by Prospective Isolation of Stem and Progenitor Cells.
    Tolu SS; Wang K; Yan Z; Zhang S; Roberts K; Crouch AS; Sebastian G; Chaitowitz M; Fornari ED; Schwechter EM; Uehlinger J; Manwani D; Minniti CP; Bouhassira EE
    Cells; 2020 Sep; 9(10):. PubMed ID: 32987729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells.
    Luck L; Zeng L; Hiti AL; Weinberg KI; Malik P
    Exp Hematol; 2004 May; 32(5):483-93. PubMed ID: 15145217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow characterization in sickle cell disease: inflammation and stress erythropoiesis lead to suboptimal CD34 recovery.
    Leonard A; Bonifacino A; Dominical VM; Luo M; Haro-Mora JJ; Demirci S; Uchida N; Pierciey FJ; Tisdale JF
    Br J Haematol; 2019 Jul; 186(2):286-299. PubMed ID: 30972754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone Marrow as a Hematopoietic Stem Cell Source for Gene Therapy in Sickle Cell Disease: Evidence from Rhesus and SCD Patients.
    Uchida N; Fujita A; Hsieh MM; Bonifacino AC; Krouse AE; Metzger ME; Donahue RE; Tisdale JF
    Hum Gene Ther Clin Dev; 2017 Sep; 28(3):136-144. PubMed ID: 28447889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collection of blood stem cells from patients with sickle cell anemia.
    Richard RE; Siritanaratkul N; Jonlin E; Skarpidi E; Heimfeld S; Blau CA
    Blood Cells Mol Dis; 2005; 35(3):384-8. PubMed ID: 16125985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HbF Levels in Sickle Cell Disease Are Associated with Proportion of Circulating Hematopoietic Stem and Progenitor Cells and CC-Chemokines.
    Minniti CP; Tolu SS; Wang K; Yan Z; Robert K; Zhang S; Crouch AS; Uehlinger J; Manwani D; Bouhassira EE
    Cells; 2020 Sep; 9(10):. PubMed ID: 33003401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered hematopoiesis in murine sickle cell disease.
    Blouin MJ; De Paepe ME; Trudel M
    Blood; 1999 Aug; 94(4):1451-9. PubMed ID: 10438733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular function reinstitution of offspring red blood cells cloned from the sickle cell disease patient blood post CRISPR genome editing.
    Wen J; Tao W; Hao S; Zu Y
    J Hematol Oncol; 2017 Jun; 10(1):119. PubMed ID: 28610635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reticulocyte parameters and hemoglobin F production in sickle cell disease patients undergoing hydroxyurea therapy.
    Borba R; Lima CS; Grotto HZ
    J Clin Lab Anal; 2003; 17(2):66-72. PubMed ID: 12640630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxyurea induction of hemoglobin F production in sickle cell disease: relationship between cytotoxicity and F cell production.
    Dover GJ; Humphries RK; Moore JG; Ley TJ; Young NS; Charache S; Nienhuis AW
    Blood; 1986 Mar; 67(3):735-8. PubMed ID: 2418898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchange transfusion.
    Lagresle-Peyrou C; Lefrère F; Magrin E; Ribeil JA; Romano O; Weber L; Magnani A; Sadek H; Plantier C; Gabrion A; Ternaux B; Félix T; Couzin C; Stanislas A; Tréluyer JM; Lamhaut L; Joseph L; Delville M; Miccio A; André-Schmutz I; Cavazzana M
    Haematologica; 2018 May; 103(5):778-786. PubMed ID: 29472357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease of very late activation antigen-4 and CD36 on reticulocytes in sickle cell patients treated with hydroxyurea.
    Styles LA; Lubin B; Vichinsky E; Lawrence S; Hua M; Test S; Kuypers F
    Blood; 1997 Apr; 89(7):2554-9. PubMed ID: 9116302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy-related changes of CD34+ progenitor cells in chronic myeloid leukemia: a morphometric study on sequential trephine biopsies.
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Goekce D; Diehl V; Zankovich R; Schaefer HE
    J Hematother Stem Cell Res; 2001 Dec; 10(6):827-36. PubMed ID: 11798509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient Generation of β-Globin-Expressing Erythroid Cells Using Stromal Cell-Derived Induced Pluripotent Stem Cells from Patients with Sickle Cell Disease.
    Uchida N; Haro-Mora JJ; Fujita A; Lee DY; Winkler T; Hsieh MM; Tisdale JF
    Stem Cells; 2017 Mar; 35(3):586-596. PubMed ID: 27739611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of 2D and 3D Erythroid Differentiation Protocols Using Sickle Cell Disease and Healthy Donor Induced Pluripotent Stem Cells.
    Martins GLS; Nonaka CKV; Rossi EA; de Lima AVR; Adanho CSA; Oliveira MS; Yahouedehou SCMA; de Souza CLEM; Gonçalves MS; Paredes BD; Souza BSF
    Cells; 2023 Apr; 12(8):. PubMed ID: 37190030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD34+ Hematopoietic Stem Cell Count Is Predictive of Vascular Event Occurrence in Children with Sickle Cell Disease.
    Kossorotoff M; De Montalembert M; Brousse V; Lasne D; Curis E; Smadja DM; Lacroix R; Bertil S; Masson E; Desguerre I; Bonnet D; Gaussem P
    Stem Cell Rev Rep; 2018 Oct; 14(5):694-701. PubMed ID: 29931411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Hydroxyurea Treatment on the Inflammatory Markers Among Children With Sickle Cell Disease.
    Zahran AM; Nafady A; Saad K; Hetta HF; Abdallah AM; Abdel-Aziz SM; Embaby MM; Abo Elgheet AM; Darwish SF; Abo-Elela MGM; Elhoufey A; Elsayh KI
    Clin Appl Thromb Hemost; 2020; 26():1076029619895111. PubMed ID: 31942811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engraftment of human hematopoietic precursor cells with secondary transfer potential in SCID-hu mice.
    Chen BP; Galy A; Kyoizumi S; Namikawa R; Scarborough J; Webb S; Ford B; Cen DZ; Chen SC
    Blood; 1994 Oct; 84(8):2497-505. PubMed ID: 7522631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial Cell-Selective Adhesion Molecule Expression in Hematopoietic Stem/Progenitor Cells Is Essential for Erythropoiesis Recovery after Bone Marrow Injury.
    Sudo T; Yokota T; Okuzaki D; Ueda T; Ichii M; Ishibashi T; Isono T; Habuchi Y; Oritani K; Kanakura Y
    PLoS One; 2016; 11(4):e0154189. PubMed ID: 27111450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine bone marrow mesenchymal stromal cells have reduced hematopoietic maintenance ability in sickle cell disease.
    Tang A; Strat AN; Rahman M; Zhang H; Bao W; Liu Y; Shi D; An X; Manwani D; Shi P; Yazdanbakhsh K; Mendelson A
    Blood; 2021 Dec; 138(24):2570-2582. PubMed ID: 34329381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.